News

May 20, 2019May 20, 2019

Investigational Alzheimer’s Therapy NNI-362 Receives FDA Approval to Enter Phase 1 Clinical Studies

Alzheimer's News, News

The U.S. Food and Drug Administration has approved Neuronascent’s investigational new drug (IND) application for NNI-362, its therapy candidate for Alzheimer’s disease, allowing it to move ahead with a ... Read more

May 17, 2019May 17, 2019

2 Planned Clinical Trials to Test Ways of Preventing Alzheimer’s at Early Stages

News

Elenbecestat and BAN2401, two potential anti-amyloid therapies, were selected by the Alzheimer’s Clinical Trials Consortium (ACTC) to be evaluated in clinical studies aiming to prevent progression to early stages of ... Read more

May 15, 2019May 15, 2019

Sleep Molecules May Represent a New Blood Biomarker for Earlier Diagnosis, Study Suggests

News

High blood levels of primary fatty acid amides (PFAMS), a class of fatty molecules involved in sleep and movement control, are associated with increased accumulation of beta-amyloid protein in ... Read more

May 12, 2019May 13, 2019

UNC Launches Training Program to Improve Dementia Patients’ Care

News

A new program called the Dementia Friendly Hospital Initiative is set to be launched in North Carolina to raise awareness among healthcare providers on how patients with Alzheimer’s disease ... Read more

May 10, 2019May 10, 2019

Family Caregivers of Dementia Patients May Benefit from Learning Positive Emotion Skills, Study Suggests

News

An online program that teaches how to focus on positive emotions can help caregivers of family members with dementia to cope better with stress, and reduce their depression and ... Read more

May 8, 2019May 8, 2019

Tetra Launches Phase 2 Trial Testing Treatment to Improve Working Memory in Older Patients

News

Tetra Discovery Partners is launching a Phase 2 clinical trial for BPN14770 — found to improve working memory in older patients in earlier trials — as a treatment for ... Read more

May 6, 2019May 6, 2019

#AANAM – Memantine as Add-on Therapy Seen to Ease Psychosis, Other Advanced Alzheimer’s Symptoms

News

Adding memantine to a cholinesterase inhibitor can significantly ease certain neuropsychiatric symptoms, including psychosis and troubling motor or nighttime behavior, in people with moderate-to-severe Alzheimer’s disease, according to pooled ... Read more

May 1, 2019

PALS Uplifts the Spirits of Rare-Disease Patients by Offering Free Flights

News

Cumbersome security procedures, rising airfares, and shrinking legroom have made commercial air travel difficult enough these days — even for healthy passengers. Imagine how much harder it is for ... Read more

May 1, 2019May 1, 2019

Long-term Treatment with Thiazide Diuretics May Lower Risk of Bone, Hip Fractures, Study Suggests

News

Long-term use of thiazide diuretics — a hypertension medication — may lower the risk of bone fractures, particularly hip fractures, in people with Alzheimer’s, a disease with a high ... Read more

April 29, 2019April 29, 2019

Simple Blood Test May Become Useful Biomarker of Alzheimer’s Progression and Treatment Response, Study Suggests

News

Blood levels of a nerve cell-derived component, known as neurofilament light chain, could be used as a biomarker of disease severity and treatment response in patients with Alzheimer’s disease, ... Read more

Pin It on Pinterest